These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 28293071)
41. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
42. Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti- Kwofie SK; Enninful KS; Yussif JA; Asante LA; Adjei M; Kan-Dapaah K; Tiburu EK; Mensah WA; Miller WA; Mosi L; Wilson MD Molecules; 2019 Jun; 24(12):. PubMed ID: 31234337 [TBL] [Abstract][Full Text] [Related]
43. Identification of novel multitarget antitubercular inhibitors against mycobacterial peptidoglycan biosynthetic Mur enzymes by structure-based virtual screening. Kumari M; Subbarao N J Biomol Struct Dyn; 2022 Nov; 40(18):8185-8196. PubMed ID: 33826470 [TBL] [Abstract][Full Text] [Related]
44. A tetrameric structure is not essential for activity in dihydrodipicolinate synthase (DHDPS) from Mycobacterium tuberculosis. Evans G; Schuldt L; Griffin MD; Devenish SR; Grant Pearce F; Perugini MA; Dobson RC; Jameson GB; Weiss MS; Gerrard JA Arch Biochem Biophys; 2011 Aug; 512(2):154-9. PubMed ID: 21672512 [TBL] [Abstract][Full Text] [Related]
45. Structural insight into conformational dynamics of non-active site mutations in KasA: A Mycobacterium tuberculosis target protein. Jayaraman M; Rajendra SK; Ramadas K Gene; 2019 Dec; 720():144082. PubMed ID: 31476406 [TBL] [Abstract][Full Text] [Related]
47. Molecular modeling approach to identify inhibitors of Rv2004c (rough morphology and virulent strain gene), a DosR (dormancy survival regulator) regulon protein from Shanmuga Priya VG; Bhandare V; Muddapur UM; Swaminathan P; Fandilolu PM; Sonawane KD J Biomol Struct Dyn; 2022 Apr; 40(7):3242-3257. PubMed ID: 33183167 [TBL] [Abstract][Full Text] [Related]
48. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants. Jagadeb M; Rath SN; Sonawane A J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826 [TBL] [Abstract][Full Text] [Related]
49. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
50. Exploring the allosteric mechanism of dihydrodipicolinate synthase by reverse engineering of the allosteric inhibitor binding sites and its application for lysine production. Geng F; Chen Z; Zheng P; Sun J; Zeng AP Appl Microbiol Biotechnol; 2013 Mar; 97(5):1963-71. PubMed ID: 22644522 [TBL] [Abstract][Full Text] [Related]
51. Computational assessment of Singh A; Kumar S; Gupta VK; Singh S; Dwivedi VD; Mina U J Biomol Struct Dyn; 2023 Jul; 41(11):4903-4916. PubMed ID: 35549811 [TBL] [Abstract][Full Text] [Related]
58. Computational evaluation of marine demospongiae sponges metabolites activity as mycolic acid biosynthesis inhibitors in Alanzi AR Int J Mycobacteriol; 2023; 12(3):332-344. PubMed ID: 37721241 [TBL] [Abstract][Full Text] [Related]
59. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis. Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108 [TBL] [Abstract][Full Text] [Related]
60. Identification of the bona fide DHDPS from a common plant pathogen. Atkinson SC; Hor L; Dogovski C; Dobson RC; Perugini MA Proteins; 2014 Sep; 82(9):1869-83. PubMed ID: 24677246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]